Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-09

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals' supplemental application for amlodipine besylate (generic). This action confirms the continued availability of a generic vers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)